The Old Peace is now live on consoles and PC this December 10 via download 2.46/1.054, and this adds a new quest.

Warframe's The Old Peace update has arrived, adding the Descendia and Perita Rebellion modes, as well as the smoochable Devil ...

Learn the features, extreme scaling, and buggy curiosities of Caliban with his brand new prime upgrade! ===TIMESTAMPS=== 0:00 Intro 0:20 Passive 1:12 Ability overview 2:10 2 - Sentient Wrath 3:11 1 - ...

For a very long time, Ash has been the absolute longest of all Warframe farms. Now that's no longer the case. Find out how much better the farm has become for him, and see how that compares to Oberon, ...

Unsurprisingly, Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) stock price was strong on the back of its healthy earnings report. However, we think that shareholders may be missing some concerning details in ...

The Dreadful Killshot build was added in the most recent Nora's Nightwave, and gives a damage and status chance bonus that scales off your Warframe's health. While you will want a total health of 1350 ...

Gyre Therapeutics, Inc. (GYRE) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.02 per share a year ago.

Warframe is a free-to-play fast-action co-op focused shooter set in an evolving sci-fi world. Set in the far reaches of outer space during a new Dark Age, WarFrame introduces the Tenno, a race on the ...

ORLANDO, Fla. – We’re truly on the downhill portion of the 2025 hurricane season, which is excellent news. With time quite literally racing by, it’ll be the end of October before we know it. It’s ...

As of September 30, 2025, the average one-year price target for Gyre Therapeutics is $19.38/share. The forecasts range from a low of $18.18 to a high of $21.00. The average price target represents an ...

The best Rafa builds in Borderlands 4 highlight the exo-soldier’s unique traits, from the solid sustain to explosive damage based on charging stacks. The challenge is to find the perfect combination ...

The global biopharmaceutical landscape is rapidly evolving, driven by innovations targeting complex diseases like organ fibrosis and liver conditions. As companies push the boundaries of medical ...